Common Stock |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
10.Common Stock The following transactions occurred during the years ended December 31, 2016, 2015 and 2014: Public Offerings January 2014 On January 21, 2014, the Company closed on a registered direct public offering of 19,047,620 shares of common stock and warrants to purchase up to 4,761,905 shares of common stock. The common stock and warrants were sold in units, consisting of a share of common stock and a warrant to purchase 0.25 shares of common stock, at a price of $1.05 per unit, and the warrants have an exercise price of $1.28 per share. The total gross proceeds of the offering were $20,000,001. The warrants issued became exercisable beginning six months and one day after the closing date, will remain exercisable until the five-year anniversary of the closing date, and were recorded as liabilities at fair value. A summary of the allocation of the proceeds of the offering is shown below:
The closing costs of $1,365,754 consisted of placement agent and other professional fees. Based upon the estimated fair value of the stock and warrants in the units, the Company allocated $206,172 to financing expense and $1,159,582 as stock issuance costs. November 2015 On November 12, 2015, the Company closed on a registered direct public offering of 16,666,667 shares of common stock and warrants to purchase up to 12,500,000 shares of common stock. The common stock and warrants were sold in units, consisting of a share of common stock and a warrant to purchase 0.75 shares of common stock, at a price of $0.42 per unit, and the warrants have an exercise price of $0.53 per share. The total gross proceeds of the offering were $7,000,000. The warrants issued became exercisable beginning six months after the closing date, will remain exercisable until the five-year anniversary of the initial exercise date, and were recorded as liabilities at fair value. A summary of the allocation of the proceeds of the offering is shown below:
The closing costs of $740,323 included 833,333 warrants valued at $174,417 and $565,906 for placement agent and other fees. Based upon the estimated fair value of the stock and warrants in the units, the Company allocated $211,116 to financing expense and $529,207 as stock issuance costs.
March 2016 On March 2, 2016, the Company closed on a registered direct public offering of 15,625,000 shares of common stock and warrants to purchase up to 11,718,750 shares of common stock. The common stock and warrants were sold in units, consisting of a share of common stock and a warrant to purchase 0.75 shares of common stock, at a price of $0.32 per unit, with an exercise price for the warrants of $0.42 per share. The total gross proceeds of the offering were $5,000,000. The issued warrants issued became exercisable beginning six months after the closing date, will remain exercisable until the five-year anniversary of the initial exercise date, and were recorded as liabilities at fair value. A summary of the allocation of the proceeds of the offering is shown below:
The closing costs of $575,751 included 781,250 warrants valued at $155,938 and $419,813 for placement agent and other fees. Based upon the estimated fair value of the stock and warrants in the units, the Company allocated $169,887 to financing expense and $405,864 as stock issuance costs. September 2016 On September 19, 2016, the Company closed on a registered direct public offering of 24,000,000 shares of common stock and warrants to purchase up to 18,000,000 shares of common stock. The common stock and warrants were sold in units, consisting of a share of common stock and a warrant to purchase 0.75 shares of common stock, at a price of $0.25 per unit, with an exercise price for the warrants of $0.30 per share. The total gross proceeds of the offering were $6,000,000. The warrants issued will become exercisable beginning six months after the closing date, and will remain exercisable until the five-year anniversary of the initial exercise date, and were recorded as liabilities at fair value. A summary of the allocation of the proceeds of the offering is shown below:
The closing costs of $575,094 included 1,440,000 warrants valued at $117,130 and $457,964 for placement agent and other fees. Based upon the estimated fair value of the stock and warrants in the units, the Company allocated $143,203 to financing expense and $431,891 as stock issuance costs.
At Market Offering On March 16, 2015, the Company entered into an at market issuance sales agreement (the “Sales Agreement”) with MLV & Co. LLC (“MLV”) pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $40 million from time to time, at its option, through MLV as its sales agent, subject to certain terms and conditions. Any shares sold will be sold pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-196255), as supplemented by a prospectus supplement dated March 16, 2015. The Company will pay MLV a commission of 3.0% of the gross proceeds of the sale of any shares sold through MLV. For the year ended December 31, 2015, the Company sold 1,407,072 shares of common stock pursuant to the Sales Agreement for $1,042,573 in gross proceeds at a weighted average price of $0.7410 per share. Net proceeds to the Company were $1,005,715 after deducting commissions and other transaction costs. Pursuant to the securities purchase agreement entered into in connection with the Company’s registered direct offering that closed on September 19, 2016, the Company is prohibited from selling any additional shares under the Sales Agreement. Compensatory Shares The Company has issued restricted shares to vendors in exchange for services. The table below summarizes the shares issued and the related market value:
Stock Option and Stock Warrant Exercises The table below summarizes stock options and stock warrants exercised:
Treasury Stock Transactions On April 14, 2014, an option holder exercised stock options by a net exercise. The Company withheld 99,010 shares in treasury as payment for the $100,000 aggregate exercise price. On December 3, 2015, the Company retired 113,215 shares of treasury stock with an aggregate purchase price of $128,410.
|